News / Events
December 3rd to 4th, 2026
The second PROMOTE Annual Meeting will be hosted by BRFAA (Athens, Greece) on 3-4 December, 2026. PROMOTE Doctoral Candidates will have the opportunity to present their research progress, participate in dedicated training activities, exchange knowledge, and strengthen collaboration across the network.
November 5th to 8th, 2026
PROMOTE Doctoral Candidates Kirubel Nigusu Jobre (DC1), Kilian Baritz (DC2), and Margarita Condyli (DC7) will present their research at the 18th European Multidisciplinary Congress on Urological Cancers (EMUC26) in Brussels, Belgium. Bringing together experts in urology, oncology, and radiology, the congress promotes multidisciplinary approaches to cancer care and offers an excellent opportunity to share PROMOTE research, exchange knowledge, and engage with the wider scientific community.
Learn more about the congress: EMUC26 – European Multidisciplinary Congress on Urological Cancers
September 1st to 30th , 2026
September is Prostate Cancer Awareness Month 💙
Prostate cancer is the most common cancer in men in 112 countries, and annual cases are projected to double to 2.9 million by 2040 (The Lancet Commission, 2024). At PROMOTE – PRostate cancer OMics Oriented inTErvention, we are working to advance our understanding of prostate cancer through omics and AI imaging driven research to improve patient stratification, disease management, and treatment guidance.
Found early, it is highly treatable. So this month, our ask is simple:
→ Know your risk: age, family history and ancestry all play a role.
→ Talk to your doctor about early detection.
→ Start the conversation with the men in your life.
Awareness saves lives. Research changes what's possible.
August 19th to 21st , 2026
🎓 PROMOTE Training School in Hannover: Turning Data into Evidence
From 19-21 August 2026, the PROMOTE Doctoral Network came together in Hannover, Germany, for a three-day Hands-on Training School on Study Design and Statistical Analysis, hosted by mosaiques diagnostics.
The course was delivered by Felix Keller from the Medical University of Innsbruck and provided our researchers with a practical foundation for designing, analysing and critically interpreting biomedical studies.
Across the three days, participants worked through key concepts including descriptive and inferential statistics, hypothesis testing, power and multiple testing, regression approaches, epidemiology, sampling and study design, bias and confounding, as well as the challenges encountered when working with real-world data. The final session also provided an opportunity to discuss participants' own datasets and analytical questions.
Beyond strengthening statistical knowledge, the Training School created an excellent opportunity for the PROMOTE researchers to exchange experiences, discuss their research challenges and learn from one another - an important part of developing the interdisciplinary skills needed for modern precision-oncology research.
A big thank you to Felix Keller for the excellent training and engaging discussions, and to all PROMOTE participants for their enthusiasm and active contribution throughout the three days!
We look forward to seeing these skills applied across the different research projects within PROMOTE. 📊🧬🔬
April 28th to 29th , 2026
We are happy to share that members of PROMOTE participated in the APCCC and IPCS Meeting in Lugano, engaging with the scientific community and contributing to insightful discussions on the latest developments in advanced prostate cancer.
https://apccc.org/ipcs-2026/
It was a great opportunity to exchange ideas, strengthen collaborations, and connect with researchers and professionals across the community.
Special thanks go to Innsbruck team for representing PROMOTE at the conference.
November 13th to 16th, 2025
The PROMOTE Doctoral Candidate Kirubel Nigusu Jobre (DC1) presented his work in a poster titled “Prospective validation of diagnostic nomograms based on mass spectrometry-based urinary biomarkers to distinguish clinically significant prostate cancer: complementing MRI pathway” at the 17th European Multidisciplinary Congress on Urological Cancers (EMUC25), taking place in Prague, Czech Republic. This congress brings together experts in urology, oncology, and radiology to advance multidisciplinary approaches in cancer care, while providing an opportunity to share and discuss PROMOTE research with the wider scientific community.
November 9th to 11th, 2025
The first PROMOTE Annual Meeting was hosted by MUI (Innsbruck, Austria). This milestone event included the project’s mid-term review and a joint workshop focused on clinical aspects of prostate cancer progression. In addition, a session on complementary skills, including scientific writing and research ethics, will be held. PROMOTE Doctoral Candidates will have the opportunity to share updates, receive training, and strengthen collaboration across the network.
October 6th, 2025
Doctoral Candidates attended the final DisCo-I (101072828) meeting held at MOS (Hannover, Germany). The event featured research presentations, career development sessions, and strategic discussions. A joint panel explored synergies between the PROMOTE, DisCo-I, and PICKED networks, fostering collaboration across MSCA projects.
October 2nd, 2025
PROMOTE Doctoral Candidates attended the MULTIR (101136926, Horizon Cancer Mission) Hybrid Symposium “Advancing Oncology with AI – Innovative Tools, Better Outcomes” in Hannover, Germany. The event brought together experts from research, healthcare, industry, and patient advocacy to explore AI’s impact on cancer management. The PROMOTE Doctoral Candidates Kirubel Nigusu Jobre (DC1), Kilian Baritz (DC2), and Margarita Kondyli (DC7) presented a poster outlining the project’s objectives and engaged with stakeholders and the broader public to discuss recent advancements in prostate cancer research.
September 11th & 30th, 2025
PROMOTE Doctoral Candidates actively participated in a webinar series on “Interpreting OMICS Data in the Context of Biology,” organized by students of the MSCA network DisCo-I (101072828), with contributions from experts across the MSCA DN PICKED (101168626) and PROMOTE (101169245). The sessions explored how OMICS technologies enhance disease understanding and offered practical resources for data interpretation.
Highlights included talks by Dr. Schanstra (INSERM) on the advantages and limitations of animal models “Omics to Improve Disease Understanding on the Molecular Biological Level: Lessons Learned from Animal Models”, Dr. Perco (Delta4) on useful OMICS interpretation tools “Useful Resources for Interpreting OMICS Data in the Molecular Biological Context”, and Dr. Zoidakis (NKUA, BRFAA) on molecular features in cancer progression “Elucidation of molecular features associated with progression of Monoclonal Gammopathies to Multiple Myeloma”.
May 5th, 2025
PROMOTE Doctoral Candidates participated in a joint training session on intellectual property, featuring “Introduction to Intellectual Property and Patents” by Prof. Argiles (RD Néphrologie SAS) and “Basics of Intellectual Property Protection” by IP Attorney Mr. Akdogan. Organized in collaboration with the DisCo-I MSCA DN programme (101072828), the session provided essential insights into protecting research innovations.
February 14th, 2025
PROMOTE Doctoral Candidates joined the webinar “(Ethical) AI & Productivity Solutions for Research” by Mr. Biglari (Doctoral Candidate in the PICKED MSCA DN programme, 101168626). The session explored how AI tools can ethically enhance research workflows and efficiency.
January 23rd to 24th, 2025
The PROMOTE Kick-off meeting took place in Hannover, Germany, bringing together Doctoral Candidates and Principal Investigators for their first in-person gathering. The event served as a valuable platform to introduce the project's vision, strategic planning, and collaborative goals. Participants engaged in discussions around the scientific objectives and operational setup, laying the groundwork for effective teamwork and coordination of activities.
December 13th, 2024
PROMOTE Doctoral Candidates attended the talk “A Synthetic Data Generation Pipeline for High-Resolution Molecular Data” by Dr. Frantzi, organized in synergy with the PerMediK COST Action (CA21165). The session highlighted innovative approaches to creating synthetic datasets to enhance statistical power in clinical studies while preserving patient privacy in molecular analysis.
The PROMOTE project has received funding from the European Union’s Horizon Europe Marie Skłodowska-Curie Actions Doctoral Networks - Industrial Doctorates Programme (HORIZON-MSCA-2023-DN-01) under grant agreement No 101169245.
